Spots Global Cancer Trial Database for fertility preservation
Every month we try and update this database with for fertility preservation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia | NCT04362046 | Endometrial Hyp... Endometrial Can... Gynecologic Can... | Hysteroscopic u... | 19 Years - 39 Years | Vancouver Coastal Health Research Institute | |
| Intra-operative Ultrasound Guided Laparoscopic Ovarian Cystectomy as a Method of Fertility Preservation | NCT05032846 | Benign Ovarian ... | Ultrasound guid... Laparoscopic Ov... | 18 Years - 50 Years | Imperial College London | |
| Increasing Access to Fertility Preservation for Women With Breast Cancer | NCT05989776 | Breast Cancer | Informational b... | 18 Years - 40 Years | University Paul Sabatier of Toulouse | |
| Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors | NCT02400970 | Minimal Residua... Fertility Prese... | malignant cells | - | University Hospital, Clermont-Ferrand | |
| Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer | NCT04586686 | Breast Cancer F... | Ovarian biopsy ... Transvaginal oo... | 18 Years - 35 Years | Universitair Ziekenhuis Brussel | |
| Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer | NCT06289751 | Cervical Cancer Neoadjuvant Che... Radical Hystere... Fertility Prese... | Cadonilimab Paclitaxel-albu... Cisplatin Extrafascial hy... | 18 Years - 70 Years | Tongji Hospital | |
| Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer | NCT06289062 | Cervical Cancer Neoadjuvant Che... Fertility Prese... | Camrelizumab Cisplatin Nab paclitaxel biopsy | 18 Years - 45 Years | Tongji Hospital | |
| Fertility Preservation in Female Cancer Patients | NCT01268592 | Fertility | oocyte vitrific... | 14 Years - 42 Years | Northwell Health | |
| Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure | NCT01160315 | Fertility Prese... Alkylating Agen... Lymphoma | Triptorelin Norethisterone ... | 18 Years - 45 Years | Erasme University Hospital | |
| DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation | NCT04616729 | Breast Cancer F... | Triptorelin 3.7... Transvaginal oo... Triptorelin Inj... | 18 Years - 35 Years | Universitair Ziekenhuis Brussel | |
| Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer | NCT06360471 | Fertility Issue... Cancer | fertility prese... | 20 Years - 40 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Ovarian Freezing Before Cancer Treatment | NCT01057745 | Effects of Chem... | 18 Years - 42 Years | University of Pennsylvania | ||
| Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry | NCT01843140 | Cancer Infertilty | 18 Years - 44 Years | University of California, San Diego | ||
| Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer | NCT04586686 | Breast Cancer F... | Ovarian biopsy ... Transvaginal oo... | 18 Years - 35 Years | Universitair Ziekenhuis Brussel | |
| Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer | NCT06360471 | Fertility Issue... Cancer | fertility prese... | 20 Years - 40 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Minimal Residual Disease Evaluation on Cryopreserved Ovarian Fragments in Younger Patients Treated for Acute Myeloid Leukemia | NCT04679285 | Acute Myeloid L... | 2 Years - 25 Years | University Hospital, Lille | ||
| Oocyte Recovery During Tamoxifen Adjuvant Therapy | NCT02355600 | Breast Cancer | Oocyte retrieva... | 18 Years - 35 Years | Instituto de Investigacion Sanitaria La Fe | |
| Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer | NCT03947151 | Invasive Ductal... | Degarelix injec... | 18 Years - 40 Years | Assistance Publique - Hôpitaux de Paris | |
| RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF | NCT01035099 | Breast Cancer Infertility | Letrozole Letrozole | 19 Years - 45 Years | Weill Medical College of Cornell University | |
| Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients | NCT03954197 | Fertility Prese... Breast Cancer | No hormone hCG GnRH a | 18 Years - 38 Years | Hôpital Jean Verdier | |
| Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia | NCT04362046 | Endometrial Hyp... Endometrial Can... Gynecologic Can... | Hysteroscopic u... | 19 Years - 39 Years | Vancouver Coastal Health Research Institute | |
| Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors | NCT02400970 | Minimal Residua... Fertility Prese... | malignant cells | - | University Hospital, Clermont-Ferrand | |
| DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation | NCT04616729 | Breast Cancer F... | Triptorelin 3.7... Transvaginal oo... Triptorelin Inj... | 18 Years - 35 Years | Universitair Ziekenhuis Brussel | |
| PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial | NCT00380406 | Fertility Prese... Cancer | Leuprolide acet... | 18 Years - 38 Years | Ottawa Hospital Research Institute | |
| Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial | NCT03011684 | Infertility | Tamoxifen Letrozole | 18 Years - 50 Years | University of California, San Francisco | |
| Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ? | NCT04487639 | Sperm Preservat... Fertility Cryopreservatio... | SARS-CoV-2 rese... | 18 Years - 60 Years | University Hospital, Clermont-Ferrand | |
| AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE) | NCT02595255 | Fertility Prese... Lymphoma Pediatrics Canc... Gonadotropin-re... | No intervention | 3 Years - 14 Years | Erasme University Hospital | |
| Contamination of Ovarian Tissue by RT-PCR in Participants With Solid Tumors | NCT02400827 | Minimal Residua... Fertility Prese... | malignant cells | - | University Hospital, Clermont-Ferrand | |
| Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients | NCT03954197 | Fertility Prese... Breast Cancer | No hormone hCG GnRH a | 18 Years - 38 Years | Hôpital Jean Verdier | |
| Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer | NCT06289062 | Cervical Cancer Neoadjuvant Che... Fertility Prese... | Camrelizumab Cisplatin Nab paclitaxel biopsy | 18 Years - 45 Years | Tongji Hospital | |
| Fertility Preservation in Male AYA With Cancer | NCT04268004 | Infertility, Ma... | FP Decision Too... | 12 Years - 25 Years | Nationwide Children's Hospital | |
| DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation | NCT04616729 | Breast Cancer F... | Triptorelin 3.7... Transvaginal oo... Triptorelin Inj... | 18 Years - 35 Years | Universitair Ziekenhuis Brussel | |
| Impact of Ionizing Treatment on the Nuclear Structure of Human Spermatozoa. | NCT04715828 | Sperm Preservat... Irradiated Seme... | Cryopreserved s... Acute and low i... Long and low ir... Long and medium... | 18 Years - 45 Years | University Hospital, Clermont-Ferrand | |
| PREgnancy and FERtility Registry | NCT02895165 | Breast Neoplasm... Pregnancy Fertility Prese... | 18 Years - 45 Years | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | ||
| Assessing Reproductive Outcomes in Young Female Cancer Survivors Through a National Fertility Preservation Registry | NCT01843140 | Cancer Infertilty | 18 Years - 44 Years | University of California, San Diego | ||
| Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia | NCT04362046 | Endometrial Hyp... Endometrial Can... Gynecologic Can... | Hysteroscopic u... | 19 Years - 39 Years | Vancouver Coastal Health Research Institute | |
| Ovarian Reserve After Cancer: Longitudinal Effects | NCT02467231 | Effects of Chem... Premature Ovari... | 11 Years - 35 Years | University of Pennsylvania | ||
| Web-based Oncofertility Support Tool for Reproductive-age Women With Breast Cancer | NCT05100498 | Breast Neoplasm... Fertility Prese... | Web-based oncof... | 20 Years - 65 Years | Mackay Medical College | |
| Fertility Preservation in Male AYA With Cancer | NCT04268004 | Infertility, Ma... | FP Decision Too... | 12 Years - 25 Years | Nationwide Children's Hospital | |
| Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer | NCT05945407 | Endometrial Neo... Endometrial Neo... Endometrial Neo... Carcinoma, Endo... Fertility Prese... | Indication-exte... | 18 Years - 45 Years | Peking University People's Hospital | |
| Cryopreservation of Ovarian Tissue | NCT01558544 | Cancer Risk of Prematu... Fertility Prese... | surgery to remo... | - 45 Years | Weill Medical College of Cornell University | |
| Advisory Board on Cancer, Infertility and Pregnancy | NCT04904263 | Cancer in Pregn... Fertility Prese... Cancer Pregnancy | - | University Hospital, Gasthuisberg | ||
| Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients | NCT00504699 | Breast Cancer | Ovarian stimula... | 18 Years - 45 Years | New York Medical College | |
| RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF | NCT01035099 | Breast Cancer Infertility | Letrozole Letrozole | 19 Years - 45 Years | Weill Medical College of Cornell University | |
| Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ? | NCT04487639 | Sperm Preservat... Fertility Cryopreservatio... | SARS-CoV-2 rese... | 18 Years - 60 Years | University Hospital, Clermont-Ferrand | |
| Impact of Gonadotoxic Therapies on Fertility | NCT05885048 | Cancer Fertility Issue... Fertility Prese... Toxicity Due to... Toxicity Due to... Effects of Immu... | Blood samples f... Sperm samples f... Satisfaction ev... Quality of Life... | 14 Years - 50 Years | Universitätsklinik fur Frauenheilkunde, Inselspital Bern | |
| AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE) | NCT02595255 | Fertility Prese... Lymphoma Pediatrics Canc... Gonadotropin-re... | No intervention | 3 Years - 14 Years | Erasme University Hospital | |
| Fertility Preservation in Male AYA With Cancer | NCT04268004 | Infertility, Ma... | FP Decision Too... | 12 Years - 25 Years | Nationwide Children's Hospital | |
| Impact of Ionizing Treatment on the Nuclear Structure of Human Spermatozoa. | NCT04715828 | Sperm Preservat... Irradiated Seme... | Cryopreserved s... Acute and low i... Long and low ir... Long and medium... | 18 Years - 45 Years | University Hospital, Clermont-Ferrand | |
| Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE) | NCT04289805 | Breast Neoplasm... | Letrozole standard-stimul... | 18 Years - 40 Years | Erasme University Hospital | |
| Fertility Preservation in Male AYA With Cancer | NCT04268004 | Infertility, Ma... | FP Decision Too... | 12 Years - 25 Years | Nationwide Children's Hospital | |
| Cryopreservation of Ovarian Tissue | NCT01558544 | Cancer Risk of Prematu... Fertility Prese... | surgery to remo... | - 45 Years | Weill Medical College of Cornell University | |
| Intra-operative Ultrasound Guided Laparoscopic Ovarian Cystectomy as a Method of Fertility Preservation | NCT05032846 | Benign Ovarian ... | Ultrasound guid... Laparoscopic Ov... | 18 Years - 50 Years | Imperial College London | |
| Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer | NCT06289751 | Cervical Cancer Neoadjuvant Che... Radical Hystere... Fertility Prese... | Cadonilimab Paclitaxel-albu... Cisplatin Extrafascial hy... | 18 Years - 70 Years | Tongji Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
